MedPath

The necessity of an injection-meal-interval in patients with type 2 diabetes mellitus and therapy with human insuli

Not Applicable
Completed
Conditions
Diabetes mellitus type 2
Nutritional, Metabolic, Endocrine
Diabetes
Registration Number
ISRCTN04277490
Lead Sponsor
niversity Hospital Jena (Germany)
Brief Summary

1. 2013 results in https://www.ncbi.nlm.nih.gov/pubmed/23340895 (added 01/02/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

1. Type 2 diabetes mellitus
2. Aged 40 - 80 years
3. Therapy with human insulin

Exclusion Criteria

1. Pregnancy
2. Nutrition disorders
3. Psychological disease
4. Body Mass Index (BMI) less than 25 kg/m^2
5. HbA1c greater than 9%

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath